Board of Scientific Counselors, Office of Infectious Diseases (BSC, OID), 17411 [2013-06433]
Download as PDF
<![CDATA[
Federal Register / Vol. 78, No. 55 / Thursday, March 21, 2013 / Notices
disabilities areas, as well as discuss health
equity recommendations to the CDC ACD.
The agenda is subject to change as
priorities dictate.
Contact Person for More Information:
Leandris Liburd, Ph.D., M.P.H., M.A.,
Designated Federal Officer, Health
Disparities Subcommittee, Advisory
Committee to the Director, CDC, 1600 Clifton
Road NE., M/S K–77, Atlanta, Georgia 30333
Telephone (770) 488–8200, Email:
LEL1@cdc.gov.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Officer, OID, CDC, 1600 Clifton Road NE.,
Mailstop D10, Atlanta, Georgia 30333,
Telephone: (404) 639–4461.
The Director, Management Analysis and
Services Office has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Dana Redford,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention (CDC).
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Dana Redford,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 2013–06433 Filed 3–20–13; 8:45 am]
BILLING CODE 4163–18–P
Centers for Disease Control and
Prevention
[FR Doc. 2013–06431 Filed 3–20–13; 8:45 am]
BILLING CODE 4163–18–P
Board of Scientific Counselors,
National Center for Health Statistics
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC), National
Center for Health Statistics (NCHS)
announces the following meeting of the
aforementioned committee:
Centers for Disease Control and
Prevention
Board of Scientific Counselors, Office
of Infectious Diseases (BSC, OID)
emcdonald on DSK67QTVN1PROD with NOTICES
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC),
announces the following meeting of the
aforementioned committee:
Time and Date: 2:00 p.m.–3:00 p.m., April
18, 2013.
Place: Teleconference.
Status: The meeting is open to the public;
the toll free dial in number is 1–877–951–
7311 with a pass code of 6420598.
Purpose: The BSC, OID, provides advice
and guidance to the Secretary, Department of
Health and Human Services; the Director,
CDC; the Director, OID; and the Directors of
the National Center for Immunization and
Respiratory Diseases, the National Center for
Emerging and Zoonotic Infectious Diseases,
and the National Center for HIV/AIDS, Viral
Hepatitis, STD, and TB Prevention, CDC, in
the following areas: strategies, goals, and
priorities for programs; research within the
national centers; and overall strategic
direction and focus of OID and the national
centers.
Matters To Be Discussed: The purpose of
the meeting is to discuss the potential for
forming an infectious disease laboratory
working group under the BSC, OID.
The agenda and any supplemental material
will be available at www.cdc.gov/oid/
BSC.html after April 1.
Agenda items are subject to change as
priorities dictate.
Contact Person for More Information:
Robin Moseley, M.A.T., Designated Federal
VerDate Mar<14>2013
15:09 Mar 20, 2013
Jkt 229001
Times and Dates: 11:00 a.m.–5:30 p.m.,
May 6, 2013, 8:30 a.m.–1:00 p.m., May 7,
2013
Place: NCHS Headquarters, 3311 Toledo
Road, Hyattsville, Maryland 20782.
Status: This meeting is open to the public;
however, visitors must be processed in
accordance with established federal policies
and procedures. For foreign nationals or nonUS citizens, pre-approval is required (please
contact Althelia Harris, 301–458–4261,
adw1@cdc.gov or Virginia Cain,
vcain@cdc.gov at least 10 days in advance for
requirements). All visitors are required to
present a valid form of picture identification
issued by a state, federal or international
government. As required by the Federal
Property Management Regulations, Title 41,
Code of Federal Regulation, Subpart 101–
20.301, all persons entering in or on Federal
controlled property and their packages,
briefcases, and other containers in their
immediate possession are subject to being xrayed and inspected. Federal law prohibits
the knowing possession or the causing to be
present of firearms, explosives and other
dangerous weapons and illegal substances.
The meeting room accommodates
approximately 100 people.
Purpose: This committee is charged with
providing advice and making
recommendations to the Secretary,
Department of Health and Human Services;
the Director, CDC; and the Director, NCHS,
regarding the scientific and technical
program goals and objectives, strategies, and
priorities of NCHS.
Matters To Be Discussed: The agenda will
include welcome remarks by the Acting
PO 00000
Frm 00063
Fmt 4703
Sfmt 4703
17411
Director, NCHS; the February 5, 2013 ORM
Program Review; discussion of revisions to
the program review protocol; program
updates.
Requests to make oral presentations should
be submitted in writing to the contact person
listed below. All requests must contain the
name, address, telephone number, and
organizational affiliation of the presenter.
Written comments should not exceed five
single-spaced typed pages in length and must
be received by April 22, 2013.
The agenda items are subject to change as
priorities dictate.
Contact Person for More Information:
Virginia S. Cain, Ph.D., Director of
Extramural Research, NCHS/CDC, 3311
Toledo Road, Room 7208, Hyattsville,
Maryland 20782, telephone (301) 458–4500,
fax (301) 458–4020.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities for
both Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Dana Redford
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 2013–06432 Filed 3–20–13; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
The meeting announced below
concerns Monitoring and Evaluation of
Malaria Control and Elimination
Activities, FOA GH13–005, initial
review.
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting:
Time and Date: 11:00 a.m.–3:00 p.m., May
21, 2013 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c) (4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters To Be Discussed: The meeting will
include the initial review, discussion, and
evaluation of applications received in
response to ‘‘Monitoring and Evaluation of
Malaria Control and Elimination Activities,
FOA GH13–005, initial review.’’
Contact Person for More Information:
Hylan D. Shoob, Ph.D., M.S.P.H., Scientific
E:\FR\FM\21MRN1.SGM
21MRN1
]]>Agencies
[Federal Register Volume 78, Number 55 (Thursday, March 21, 2013)]
[Notices]
[Page 17411]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-06433]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Board of Scientific Counselors, Office of Infectious Diseases
(BSC, OID)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC), announces the following meeting of the aforementioned
committee:
Time and Date: 2:00 p.m.-3:00 p.m., April 18, 2013.
Place: Teleconference.
Status: The meeting is open to the public; the toll free dial in
number is 1-877-951-7311 with a pass code of 6420598.
Purpose: The BSC, OID, provides advice and guidance to the
Secretary, Department of Health and Human Services; the Director,
CDC; the Director, OID; and the Directors of the National Center for
Immunization and Respiratory Diseases, the National Center for
Emerging and Zoonotic Infectious Diseases, and the National Center
for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, CDC, in the
following areas: strategies, goals, and priorities for programs;
research within the national centers; and overall strategic
direction and focus of OID and the national centers.
Matters To Be Discussed: The purpose of the meeting is to
discuss the potential for forming an infectious disease laboratory
working group under the BSC, OID.
The agenda and any supplemental material will be available at
www.cdc.gov/oid/BSC.html after April 1.
Agenda items are subject to change as priorities dictate.
Contact Person for More Information: Robin Moseley, M.A.T.,
Designated Federal Officer, OID, CDC, 1600 Clifton Road NE.,
Mailstop D10, Atlanta, Georgia 30333, Telephone: (404) 639-4461.
The Director, Management Analysis and Services Office has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention
and the Agency for Toxic Substances and Disease Registry.
Dana Redford,
Acting Director, Management Analysis and Services Office, Centers for
Disease Control and Prevention.
[FR Doc. 2013-06433 Filed 3-20-13; 8:45 am]
BILLING CODE 4163-18-P
